Trials / Completed
CompletedNCT00610142
Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Technische Universität Dresden · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
to explore the atrophogenic potentials of hydrocortison 1% cream and pimecrolimus 1% cream on unaffected forehead skin
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pimecrolimus 1% cream | twice a day one fingertip at a 2 times 2 cm2 area of uninvolved skin on the lateral forehead for 4 weeks |
| DRUG | hydrocortison 1% cream | twice a day one fingertip at a 2 times 2 cm2 area of uninvolved skin on the lateral forehead for 4 weeks |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2008-08-01
- Completion
- 2009-01-01
- First posted
- 2008-02-07
- Last updated
- 2014-06-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00610142. Inclusion in this directory is not an endorsement.